Current and Future Trends in the Treatment of Renal Cancer{A figure is presented}

European Urology, Supplements

Volumn 6, Issue 3, 2007, Pages 374-384

  Keane, Thomas ^a   Gillatt, David ^b   Evans, Christopher P ^c   Tubaro, Andrea ^d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Immunotherapy; Inferior vena cava; Laparoscopic nephrectomy; Partial nephrectomy; Radical nephrectomy; Renal cell cancer; Renal metastases; Thrombus

Indexed keywords

4 (4 FLUORO 2 METHYL 5 INDOLYLOXY) 6 METHOXY 7 [3 (1 PYRROLIDINYL)PROPOXY]QUINAZOLINE; ALPHA INTERFERON; ALPHA2B INTERFERON; AXITINIB; INTERLEUKIN 2; PROTEIN TYROSINE KINASE INHIBITOR; SORAFENIB; SUNITINIB;

ARTIFICIAL EMBOLISM; BLISTER; CANCER IMMUNOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CRYOABLATION; DIARRHEA; DRUG WITHDRAWAL; FATIGUE; HUMAN; HYPERTENSION; KIDNEY CANCER; LIMB PAIN; METASTASIS; NEPHRON SPARING SURGERY; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; TUMOR THROMBUS;

EID: 33846405692     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2006.12.006     Document Type: Review

References (41)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. Available at http://www-depdb.iarc.fr. Accessed 19 March 2004.
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
3. Godley P.A., and Taylor M. Renal cell carcinoma. Curr Opin Oncol 13 (2001) 199-203
4. Motzer R.J., Mazumdar M., Bacik J., Russo P., Berg W.J., and Metz E.M. Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma. J Clin Oncol 18 (2000) 1928-1935
5. Amato R.J. Chemotherapy for renal cell carcinoma. Semin Oncol 27 (2000) 177-186
6. Gillatt D., Keane T., and Miller K. Preface. Eur Urol Suppl 6 (2007) 325-326
7. Parekh D.J., Cookson M.S., Chapman W., et al. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes. J Urol 173 (2005) 1897-1902
8. Zisman A., Wieder J.A., Pantuck A.J., et al. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol 169 (2003) 909-916
9. Moinzadeh A., and Libertino J.A. Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same?. J Urol 171 (2004) 598-601
10. Bissada N.K., Yakout H.H., Babanouri A., et al. Long-term experience with management of renal cell carcinoma involving the inferior vena cava. Urology 61 (2003) 89-92
11. Kaplan S., Ekici S., Dogan R., Demircin M., Ozen H., and Pasaoglu I. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Am J Surg 183 (2002) 292-299
12. Ljungberg B, Hanbury DC, Kuczyk MA, et al. Guidelines on renal cell carcinoma. Available at http://www.uroweb.nl/files/uploaded_files/guidelines/08%20Renal%20Cell%20Carcinoma.pdf. Accessed 31 October 2006.
13. Rodriguez A., and Sexton W.J. Management of locally advanced renal cell carcinoma. Cancer Control 13 (2006) 199-210
14. Pantuck A.J., Zisman A., Dorey F., et al. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. Cancer 97 (2003) 2995-3002
15. Flanigan R.C., Salmon S.E., Blumenstein B.A., et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 345 (2001) 1655-1659
16. Mickisch G.H.J., Garin A., Van Poppel H., de Prijck L., Sylvester R., and and members of the European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358 (2001) 966-970
17. Schafhauser W., Ebert A., Brod J., Petsch S., and Schrott K.M. Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy. Anticancer Res 19 (1999) 1573-1578
18. Siminovitch J.P., Montie J.E., and Straffon R.A. Lymphadenectomy in renal adenocarcinoma. J Urol 127 (1982) 1090-1091
19. Minervini A., Lilas L., Morelli G., et al. Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery?. BJU Int 88 (2001) 169-172
20. Pantuck A.J., Zisman A., Dorey F., et al. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 169 (2003) 2076-2083
21. Peters P.C., and Brown G.L. The role of lymphadenectomy in the management of renal cell carcinoma. Urol Clin North Am 7 (1980) 705-709
22. Joslyn S.A., Sirintrapun S.J., and Konety B.R. Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National Surveillance, Epidemiology, and End Results database. Urology 65 (2005) 675-680
23. Motzer R.J., Bander N.H., and Nanus D.M. Renal-cell carcinoma. N Engl J Med 335 (1996) 865-875
24. Motzer R.J., Hutson T.E., Tomczak P., et al. Phase III randomized trial of sunitinib malate (SU11248) versus interferon-alpha (IFN-α) as first-line systemic therapy for patients with metastatic renal cell carcinoma (mRCC). J Clin Oncol 24 (2006) 18S (meeting abstracts)
25. Escudier B, Szczylik C, Eisen T, et al. Randomized phase III trial of the multi-kinase inhibitor sorafenib (BAY 43-9006) in patients with advanced RCC. ECCO 13-the European Cancer Conference, November 3, 2005, Paris, France.
26. Rini B, Rixe O, Bukowski R, et al. AG-013736, a multi-target tyrosine kinase receptor inhibitor, demonstrates anti-tumor activity in a Phase 2 study of cytokine-refractory, metastatic renal cell cancer (RCC). 2005 ASCO Annual Meeting Proceedings. J Clin Oncol 2005;23 (abstract no. 4509).
27. Study of AG-013736 in patients with refractory metastatic renal cell cancer. Available at http://clinicaltrials.gov/ct/show/NCT00282048?order=1. Accessed 24 November 2006.
28. AZD2171 in treating patients with refractory kidney cancer. Available at http://clinicaltrials.gov/ct/show/NCT00303862?order=1. Accessed 24 November 2006.
29. Lee C.T., Katz J., Shi W., Thaler H.T., Reuter V.E., and Russo P. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol 163 (2000) 730-736
30. Chawla S.N., Crispen P.L., Hanlon A.L., Chen D.Y.T., Greenberg R.E., and Uzzo R.G. Observation of enhancing renal masses: a meta-analysis of worldwide data. J Urol 173 (2005) 361 (abstract no. 1329)
31. Lamb G.W.A., Bromwich E.J., Vasey P., and Aitchison M. Management of renal masses in patients medically unsuitable for nephrectomy-natural history, complications, and outcome. Urology 64 (2004) 909-913
32. Volpe A., and Jewett M.A. The natural history of small renal masses. Nat Clin Pract Urol 2 (2005) 384-390
33. Belldegrun A., Tsui K.H., deKernion J.B., and Smith R.B. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol 17 (1999) 2868-2875
34. Patard J.J., Shvarts O., Lam J.S., et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 171 (2004) 2181-2185
35. Hafez K.S., Fergany A.F., and Novick A.C. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 162 (1999) 1930-1933
36. Fergany A.F., Hafez K.S., and Novick A.C. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 163 (2000) 442-445
37. Haber G.-P., and Gill I.S. Laparoscopic partial nephrectomy: contemporary technique and outcomes. Eur Urol 49 (2006) 660-665
38. Gill I.S., Colombo Jr. J.R., Moinzadeh A., et al. Laparoscopic partial nephrectomy in solitary kidney. J Urol 175 (2006) 454-458
39. Davol P.E., Fulmer B.R., and Rukstalis D.B. Long-term results of cryoablation for renal cancer and complex renal masses. Urology 68 suppl 1A (2006) 2-6
40. Veltri A., Calvo A., Tosetti I., et al. Experiences in US-guided percutaneous radiofrequency ablation of 44 renal tumors in 31 patients: analysis of predictors for complications and technical success. Cardiovasc Intervent Radiol 29 (2006) 811-818
41. Memarsadeghi M., Schmook T., Remzi M., et al. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients. Eur J Radiol 59 (2006) 183-189